ArticleCancer immunology, immunotherapy : CII2024

Long-term survivals of immune checkpoint inhibitors as neoadjuvant and adjuvant therapy in dMMR/MSI-H colorectal and gastric cancers.

Zhenghang Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.